tiprankstipranks
Biofrontera AG (DE:B8FK)
XETRA:B8FK
Germany Market
B8FK
Biofrontera
RESEARCH TOOLSreports

Biofrontera (B8FK) Ratios

3 Followers

Biofrontera Ratios

DE:B8FK's free cash flow for Q4 2023 was €―. For the 2023 fiscal year, DE:B8FK's free cash flow was decreased by € and operating cash flow was €―. See a summary of the company’s cash flow.
Ratios
TTM
Mar 24Mar 23Mar 22Mar 21
Liquidity Ratios
Current Ratio
 1.20----
Quick Ratio
 1.09----
Cash Ratio
 0.58----
Solvency Ratio
 -0.56----
Operating Cash Flow Ratio
 -0.85----
Short-Term Operating Cash Flow Coverage
 -18.41----
Net Current Asset Value
€ -5.56M€ 6.97M€ 2.67M€ -4.32M€ -22.89M
Leverage Ratios
Debt-to-Assets Ratio
 0.31----
Debt-to-Equity Ratio
 1.27----
Debt-to-Capital Ratio
 0.56----
Long-Term Debt-to-Capital Ratio
 0.54----
Financial Leverage Ratio
 4.08----
Debt Service Coverage Ratio
 -11.41----
Interest Coverage Ratio
 -40.36----
Debt to Market Cap
 0.68----
Interest Debt Per Share
 0.68----
Net Debt to EBITDA
 -0.17 -0.35 -2.09 0.29 -26.46
Profitability Margins
Gross Profit Margin
82.79%----
EBIT Margin
-20.64%----
EBITDA Margin
-19.14%----
Operating Profit Margin
-20.64%----
Pretax Profit Margin
-25.60%----
Net Profit Margin
-25.66%----
Continuous Operations Profit Margin
-25.66%----
Net Income Per EBT
100.24%----
EBT Per EBIT
123.98%----
Return on Assets (ROA)
-44.72%-1.20%-134.96%49.58%-23.09%
Return on Equity (ROE)
-476.72%-1.85%-217.18%65.73%-176.58%
Return on Capital Employed (ROCE)
-64.33%23.15%6.53%-27.07%-11.66%
Return on Invested Capital (ROIC)
-62.07%22.08%6.42%-24.66%-11.39%
Return on Tangible Assets
-49.98%-1.25%-140.09%50.34%-33.65%
Earnings Yield
-107.09%-0.06%-2.46%2.14%-0.39%
Efficiency Ratios
Receivables Turnover
 11.14----
Payables Turnover
 2.05----
Inventory Turnover
 6.04----
Fixed Asset Turnover
 8.52----
Asset Turnover
 1.74----
Working Capital Turnover Ratio
 10.26----
Cash Conversion Cycle
 -85.18 215.08 247.09 213.22 357.00
Days of Sales Outstanding
 32.77 83.35 31.44 19.30 42.17
Days of Inventory Outstanding
 60.42 269.35 367.92 449.04 482.37
Days of Payables Outstanding
 178.38 137.62 152.26 255.12 167.53
Operating Cycle
 93.20 352.69 399.36 468.34 524.54
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.80----
Free Cash Flow Per Share
 -0.80----
CapEx Per Share
 <0.01----
Free Cash Flow to Operating Cash Flow
 1.00----
Dividend Paid and CapEx Coverage Ratio
 -2.33K----
Capital Expenditure Coverage Ratio
 -2.33K----
Operating Cash Flow Coverage Ratio
 -1.21----
Operating Cash Flow to Sales Ratio
 -0.22----
Free Cash Flow Yield
-82.14%-0.48%-0.27%1.69%-0.11%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.93----
Price-to-Sales (P/S) Ratio
 0.26----
Price-to-Book (P/B) Ratio
 1.71----
Price-to-Free Cash Flow (P/FCF) Ratio
 -1.22----
Price-to-Operating Cash Flow Ratio
 -1.11----
Price-to-Earnings Growth (PEG) Ratio
 -0.03----
Price-to-Fair Value
 1.71----
Enterprise Value Multiple
 -1.54----
Enterprise Value
 12.75M 587.64M 1.79B 1.76B 3.35B
EV to EBITDA
 -1.54 105.44 767.44 -139.73 -12.11K
EV to Sales
 0.30 18.22 69.68 61.12 110.55
EV to Free Cash Flow
 -1.37 -207.72 -367.83 59.02 -925.99
EV to Operating Cash Flow
 -1.37 -306.54 -460.47 57.80 -1.18K
Tangible Book Value Per Share
 0.30----
Shareholders’ Equity Per Share
 0.52----
Tax and Other Ratios
Effective Tax Rate
 >-0.01----
Revenue Per Share
 3.70----
Net Income Per Share
 -0.95----
Tax Burden
 1.00 -0.07 1.02 1.06 1.03
Interest Burden
 1.24 1.07 -27.16 -2.25 2.26
Research & Development to Revenue
 0.08 0.24 0.28 0.24 0.16
SG&A to Revenue
 0.94 0.19 0.23 1.07 0.30
Stock-Based Compensation to Revenue
 0.02 0.00 0.00 0.00 0.02
Income Quality
 0.84 5.20 0.09 0.85 0.22
Currency in EUR